AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 194 filers reported holding AMAG PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $275,000 | -40.2% | 22,616 | -43.2% | 0.00% | -50.0% |
Q3 2019 | $460,000 | -12.0% | 39,816 | -24.0% | 0.01% | 0.0% |
Q2 2019 | $523,000 | -24.2% | 52,380 | -2.2% | 0.01% | -25.0% |
Q1 2019 | $690,000 | -14.6% | 53,550 | +0.7% | 0.01% | -20.0% |
Q4 2018 | $808,000 | -19.2% | 53,185 | +6.4% | 0.01% | +11.1% |
Q3 2018 | $1,000,000 | +2.8% | 50,008 | +0.2% | 0.01% | -10.0% |
Q2 2018 | $973,000 | -10.2% | 49,923 | -7.1% | 0.01% | -9.1% |
Q1 2018 | $1,083,000 | +37.4% | 53,755 | -9.6% | 0.01% | +37.5% |
Q4 2017 | $788,000 | +133.1% | 59,455 | +224.9% | 0.01% | +100.0% |
Q3 2017 | $338,000 | +0.3% | 18,300 | 0.0% | 0.00% | -20.0% |
Q2 2017 | $337,000 | -16.6% | 18,300 | +2.2% | 0.01% | -16.7% |
Q1 2017 | $404,000 | -34.0% | 17,900 | +1.7% | 0.01% | -33.3% |
Q4 2016 | $612,000 | +41.0% | 17,600 | -0.6% | 0.01% | +28.6% |
Q3 2016 | $434,000 | +0.7% | 17,700 | -1.7% | 0.01% | +16.7% |
Q2 2016 | $431,000 | +2.9% | 18,000 | +0.6% | 0.01% | +20.0% |
Q1 2016 | $419,000 | – | 17,900 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bleichroeder LP | 1,299,994 | $12,220,000 | 2.19% |
Camber Capital Management LP | 8,780,000 | $82,532,000 | 2.18% |
Palo Alto Investors LP | 3,003,875 | $28,236,000 | 1.55% |
ARMISTICE CAPITAL, LLC | 4,120,000 | $38,728,000 | 1.40% |
Permanens Capital L.P. | 359,311 | $3,378,000 | 1.17% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 31,582 | $297,000 | 0.21% |
BOOTHBAY FUND MANAGEMENT, LLC | 348,000 | $3,271,000 | 0.20% |
Teza Capital Management LLC | 20,300 | $191,000 | 0.11% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 767,135 | $7,211,000 | 0.08% |
Livforsakringsbolaget Skandia, Omsesidigt | 38,800 | $365,000 | 0.04% |